fludarabine phosphate
- Product NDC
- 24201-237
- 11-digit product format
- 242010237
- Labeler code
- 24201
- Product ID
- 24201-237_f1ed1d03-2d86-90da-e053-2a95a90a8c4d
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- fludarabine phosphate
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Hikma Pharmaceuticals USA Inc. (dba Leucadia Pharmaceuticals)
- Application
- ANDA076349
- Marketing category
- ANDA
- Marketing start
- 2017-12-13
- Marketing end
- 0000-00-00
- Substance
- FLUDARABINE PHOSPHATE
- Active strength
- 25 mg/mL
- Pharmacologic classes
- Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2024-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 24201-237-01 | 24201023701 | 1 VIAL in 1 CARTON (24201-237-01) > 2 mL in 1 VIAL | 1 vial | 2017-12-13 | 0000-00-00 | No | No | Current |